$80.96
+1.98 (+2.51%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+3.05%
1Y
+63.23%
YTD
+5.50%
Open$80.00
Previous Close$78.98
Day High$81.71
Day Low$79.51
52W High$87.50
52W Low$43.18
Volume—
Avg Volume2.43M
Market Cap6.55B
P/E Ratio886.87
EPS$4.49
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.08
Above
SMA 200
$61.55
Above
RSI (14)
25.1
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-3.7% upside
Current
$80.96
$80.96
Target
$77.98
$77.98
$54.55
$77.98 avg
$125.35
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.63B | 1.17B | 623.61M |
| Net Income | 641.20M | 414.48M | 103.27M |
| Profit Margin | 39.4% | 37.5% | 16.6% |
| EBITDA | 837.54M | 571.47M | 195.81M |
| Free Cash Flow | — | — | 61.49M |
| Rev Growth | +128.3% | +35.3% | +11.8% |
| Debt/Equity | 0.51 | 848.93 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |